Obesity-Associated with Prediabetes Increases the Risk of Breast Cancer Development and Progression- A Study on an Obese Rat Model with Impaired Glucose Tolerance
Preprint
- 17 May 2023
- preprint
- Published by MDPI AG in Preprints.org
Abstract
It was found that patients with comorbidities of obesity and diabetes have a high risk of breast cancer occurrence and face worse breast cancer outcomes. Though several reports showed the reinforced link between obesity, diabetes, and prediabetes with breast cancer, the underlying molecular mechanism is still unknown. The present study aimed to investigate the underlying molecular link between increased risks of breast cancer due to coincident diabetes or obesity using a spontaneous obese rat model with impaired glucose tolerance (WNIN/GR-Ob rat). A single dose of solubilized DMBA suspension (40 mg/kg body weight) was orally administered to the animals at the age of 60 days to induce breast tumors. The tumor incidence, latency period, tumor frequency, and tumor volume were measured. Histology, immunohistochemistry, and immunoblotting were performed to evaluate the tumor morphology and expression levels of signal molecules. It was observed that the onset of breast tumor and latency period per tumor development were early in GR-Ob rats compared to respective lean rats. It was found that 62% of obese rats were bearing tumors, and in comparison, only 21% of the lean animals developed breast tumors. Overexpression of ER, PR, Ki67, and p53 markers was observed in tumor tissues of obese rats in comparison with lean rats. The levels of the hallmarks of cell proliferation and angiogenesis involved in IGF-1/PI3K/Akt/GSK3β/β-catenin signaling pathway molecules were upregulated in obese rat breast tumors compared to lean rats. Furthermore, obesity with prediabetes is associated with changes in IGF-1 signaling and acts on PI3K/Akt/GSK3β/β-catenin signaling, which results in quick cell proliferation and development of breast tumors in obese rats than the lean rats. These results indicate that the onset of the tumor and its development was faster in a spontaneous obese rat model with impaired glucose tolerance than their lean counterparts, with a higher percentage of tumor incidence.Keywords
All Related Versions
This publication has 64 references indexed in Scilit:
- Breast cancer risk for women with diabetes and the impact of metformin: A meta‐analysisCancer Medicine, 2022
- Association of Body Mass Index With 21-Gene Recurrence Score Among Women With Estrogen Receptor–Positive, ERBB2–Negative Breast CancerJAMA Network Open, 2022
- Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studiesDiabetologia, 2021
- Metabolic Syndrome: does this influence breast cancer outcomes in the triple-negative population?Breast Cancer Research and Treatment, 2021
- Metabolic syndrome and early stage breast cancer outcome: results from a prospective observational studyBreast Cancer Research and Treatment, 2020
- Progesterone receptor status modifies the association between body mass index and prognosis in women diagnosed with estrogen receptor positive breast cancerInternational Journal of Cancer, 2019
- Differences in prognosis and efficacy of chemotherapy by p53 expression in triple-negative breast cancerBreast Cancer Research and Treatment, 2018
- Risk Differences Between Prediabetes And Diabetes According To Breast Cancer Molecular SubtypesJournal of Cellular Physiology, 2016
- Prediabetes and the risk of cancer: a meta-analysisDiabetologia, 2014
- Insulin‐like growth factor I and risk of breast cancer by age and hormone receptor status—A prospective study within the EPIC cohortInternational Journal of Cancer, 2013